Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Celldex Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 161
- +30 vs. Q2 2021
- Shares held
- 43.0M
- +7.72M (+21.9%) vs. Q2 2021
- Total value
- $2.33B
- +$1.14B (+95.6%) vs. Q2 2021
- New holders
- 44
- 53 more added
- Sold out
- 14
- 46 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 253 | $3.16B |
| Q1 2026 | 229 | $2.31B |
| Q4 2025 | 187 | $1.99B |
| Q3 2025 | 184 | $1.83B |
| Q2 2025 | 182 | $1.48B |
| Q1 2025 | 171 | $1.34B |
| Q4 2024 | 174 | $1.86B |
| Q3 2024 | 176 | $2.44B |
| Q2 2024 | 183 | $2.58B |
| Q1 2024 | 197 | $2.91B |
| Q4 2023 | 164 | $2.42B |
| Q3 2023 | 144 | $1.39B |
| Q2 2023 | 150 | $1.70B |
| Q1 2023 | 161 | $1.78B |
| Q4 2022 | 168 | $2.17B |
| Q3 2022 | 160 | $1.39B |
| Q2 2022 | 158 | $1.30B |
| Q1 2022 | 169 | $1.69B |
| Q4 2021 | 181 | $1.79B |
| Q3 2021 | 161 | $2.33B |
| Q2 2021 | 132 | $1.19B |
| Q1 2021 | 115 | $709.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Celldex Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rhumbline Advisers | 49,265 | $2.66M | 0.00% | +8,430+20.6% | Added |
| State of Wisconsin Investment Board | 50,700 | $2.74M | 0.01% | +1,000+2.0% | Added |
| California State Teachers Retirement System | 56,683 | $3.06M | 0.00% | +2,604+4.8% | Added |
| Schonfeld Strategic Advisors LLC | 56,807 | $3.07M | 0.03% | −20,073−26.1% | Reduced |
| Rafferty Asset Management, LLC | 57,144 | $3.08M | 0.02% | −21,357−27.2% | Reduced |
| TD Asset Management Inc | 62,329 | $3.37M | 0.00% | +17,400+38.7% | Added |
| Caption Management, LLC | 73,000 | $3.94M | 0.26% | +73,000 | New |
| Mirador Capital Partners LP | 73,716 | $3.98M | 0.90% | −4,963−6.3% | Reduced |
| Pura Vida Investments, LLC | 77,285 | $4.17M | 0.31% | −27,771−26.4% | Reduced |
| Swiss National Bank | 85,300 | $4.61M | 0.00% | −1,900−2.2% | Reduced |
| EAM Investors, LLC | 86,399 | $4.67M | 0.79% | +35,866+71.0% | Added |
| Principal Financial Group Inc | 93,428 | $5.04M | 0.00% | +9,563+11.4% | Added |
| EAM Global Investors LLC | 96,528 | $5.21M | 1.23% | +25,290+35.5% | Added |
| Voloridge Investment Management, LLC | 102,146 | $5.51M | 0.04% | +102,146 | New |
| Citigroup Inc | 109,309 | $5.90M | 0.01% | −10,945−9.1% | Reduced |
| D. E. Shaw & Co., Inc. | 113,924 | $6.15M | 0.01% | +83,625+276.0% | Added |
| Sphera Funds Management Ltd. | 130,330 | $7.04M | 0.70% | +130,330 | New |
| Sofinnova Investments, Inc. | 137,032 | $7.40M | 0.47% | +2,308+1.7% | Added |
| Nuveen Asset Management, LLC | 147,488 | $8.02M | 0.00% | +5,457+3.8% | Added |
| Susquehanna International Group, LLP | 153,960 | $8.31M | 0.01% | +47,512+44.6% | Added |
| Renaissance Technologies LLC | 161,276 | $8.71M | 0.01% | −202,751−55.7% | Reduced |
| AXA S.A. | 162,983 | $8.80M | 0.02% | −65,968−28.8% | Reduced |
| Bank of New York Mellon Corp | 172,746 | $9.33M | 0.00% | +56,311+48.4% | Added |
| Morgan Stanley | 177,536 | $9.58M | 0.00% | +54,377+44.2% | Added |
| Candriam Luxembourg S.C.A. | 180,222 | $9.73M | 0.07% | −219,463−54.9% | Reduced |
| Altium Capital Management LP | 185,000 | $9.99M | 2.66% | +91,884+98.7% | Added |
| JPMorgan Chase & Co | 211,453 | $11.4M | 0.00% | +196,264+1,292.1% | Added |
| Commodore Capital LP | 248,207 | $13.4M | 3.53% | −75,230−23.3% | Reduced |
| Ghost Tree Capital, LLC | 255,000 | $13.8M | 4.54% | −30,000−10.5% | Reduced |
| Ikarian Capital, LLC | 270,431 | $14.6M | 3.34% | −95,113−26.0% | Reduced |
| TSP Capital Management Group, LLC | – | $14.7M | 5.00% | – | – |
| Goldman Sachs Group Inc | 307,679 | $16.6M | 0.00% | −30,376−9.0% | Reduced |
| Charles Schwab Investment Management Inc | 322,456 | $17.4M | 0.01% | +224,831+230.3% | Added |
| Acuta Capital Partners, LLC | 337,500 | $18.2M | 6.49% | −649,906−65.8% | Reduced |
| Dimensional Fund Advisors LP | 358,634 | $19.4M | 0.01% | −790−0.2% | Reduced |
| Perceptive Advisors LLC | 393,613 | $21.3M | 0.31% | −349,086−47.0% | Reduced |
| OrbiMed Advisors LLC | 414,300 | $22.4M | 0.25% | +414,300 | New |
| Northern Trust Corp | 459,113 | $24.8M | 0.00% | +46,850+11.4% | Added |
| Vivo Capital, LLC | 484,453 | $26.2M | 1.17% | −484,453−50.0% | Reduced |
| Fred Alger Management, LLC | 525,867 | $28.4M | 0.07% | +525,867 | New |
| Invesco Ltd. | 533,985 | $28.8M | 0.01% | +103,578+24.1% | Added |
| Driehaus Capital Management LLC | 551,065 | $29.8M | 0.35% | −34,246−5.9% | Reduced |
| Cowen and Company, LLC | 649,278 | $35.1M | 1.69% | +620,883+2,186.6% | Added |
| Polar Capital Holdings Plc | 722,843 | $39.0M | 0.21% | +222,843+44.6% | Added |
| Octagon Capital Advisors LP | 761,398 | $41.1M | 10.12% | +200,000+35.6% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 762,296 | $41.2M | 0.11% | +762,296 | New |
| Citadel Advisors LLC | 783,061 | $42.3M | 0.05% | +411,890+111.0% | Added |
| Geode Capital Management, LLC | 792,507 | $42.8M | 0.01% | +119,559+17.8% | Added |
| Price T Rowe Associates Inc | 878,409 | $47.4M | 0.00% | +489,361+125.8% | Added |
| Adage Capital Partners GP, L.L.C. | 950,000 | $51.3M | 0.10% | −868,478−47.8% | Reduced |
| Opaleye Management Inc. | 985,000 | $53.0M | 9.91% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,098,174 | $59.3M | 7.62% | −142,436−11.5% | Reduced |
| Eventide Asset Management, LLC | 1,128,000 | $60.9M | 0.81% | −980,908−46.5% | Reduced |
| Ra Capital Management, L.P. | 1,600,000 | $86.4M | 1.20% | +1,600,000 | New |
| State Street Corp | 1,857,118 | $100.3M | 0.01% | −237,100−11.3% | Reduced |
| Wellington Management Group LLP | 2,180,352 | $117.7M | 0.02% | +217,353+11.1% | Added |
| Vanguard Group Inc | 2,276,199 | $122.9M | 0.00% | +305,793+15.5% | Added |
| Redmile Group, LLC | 3,043,298 | $164.3M | 2.87% | +31,217+1.0% | Added |
| BlackRock Inc. | 3,133,770 | $169.2M | 0.00% | +433,120+16.0% | Added |
| RTW Investments, LP | 3,908,947 | $211.0M | 3.18% | 00.0% | Unchanged |
| FMR LLC | 5,615,333 | $303.2M | 0.02% | +5,249,038+1,433.0% | Added |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −457,666−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −175,305−100.0% | Sold out |
| DSAM Partners (London) Ltd | 0 | $0 | 0.00% | −135,907−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −87,736−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −51,400−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −32,200−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −15,180−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −9,861−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −9,769−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −7,075−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −7,053−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Enterprise Financial Services Corp | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| First Horizon Corp | – | – | – | – | Not filed |